These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs]. Seigneurie AS; Sauvanaud F; Limosin F Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134 [TBL] [Abstract][Full Text] [Related]
5. Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia. Dilks S; Xavier RM; Kelly C; Johnson J Nurs Clin North Am; 2019 Dec; 54(4):595-608. PubMed ID: 31703784 [TBL] [Abstract][Full Text] [Related]
6. Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia. McEvoy JP J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846247 [TBL] [Abstract][Full Text] [Related]
7. Clinical management of tardive dyskinesia: Five steps to success. Citrome L J Neurol Sci; 2017 Dec; 383():199-204. PubMed ID: 29246613 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment. Correll CU; Kane JM; Citrome LL J Clin Psychiatry; 2017; 78(8):1136-1147. PubMed ID: 29022654 [TBL] [Abstract][Full Text] [Related]